Tag Archives: Indian pharmaceutical market FY27

Generic Semaglutide Patent Expiry Unlocks Rs. 50,000 Cr Opportunity for Pharma Industry

The upcoming patent expiry of semaglutide, a leading GLP-1 therapy […]